Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00490074 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers

Study acronym: EV03/ANRSVAC20
StatusCompleted
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Lead sponsor: French National Agency for Research on AIDS and Viral Hepatitis to ANRS, Emerging Infectious Diseasesv9
  2. Trial status: Active, Not Recruiting to Completed Enrollment target: estimated 140 to confirmed 147 · Eligibility criteria expanded, about 22 words · Study description revised · 1 morev8 Show 4 more changesShow less
    • Enrollment target: estimated 140 to confirmed 147
    • Eligibility criteria expanded, about 22 words
    • Study description revised
    • Study arms: 0 to 2

    See this version in full on ClinicalTrials.gov ↗

  3. Study sites: 3 to 2 Start date: Nov 2007 to Jul 2007 · Secondary endpoints: details revised at 2 of 7 entriesv7 Show 2 more changesShow less
    • Start date: Nov 2007 to Jul 2007
    • Secondary endpoints: details revised at 2 of 7 entries
  4. Start date: Jun 2007 to Nov 2007 Trial status: Recruiting to Active, Not Recruiting · Primary completion date: Mar 2009 to Dec 2008 · Completion date: Mar 2009 to Oct 2009 · 1 morev6 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Mar 2009 to Dec 2008
    • Completion date: Mar 2009 to Oct 2009
    • Site details revised at 3 of 3 sites
  5. Primary completion date: Mar 2009 Site details revised at 1 of 3 sitesv5 Show 1 more changeShow less
    • Site details revised at 1 of 3 sites
Show 3 earlier versionsHide 3 earlier versions
  1. Completion date: Feb 2009 to Mar 2009 Start date: Jul 2007 to Jun 2007v4 Show 1 more changeShow less
    • Start date: Jul 2007 to Jun 2007
  2. Trial status: Not Yet Recruiting to Recruiting Start date: Jul 2007 · Site details revised at 3 of 3 sitesv3 Show 2 more changesShow less
    • Start date: Jul 2007
    • Site details revised at 3 of 3 sites
  3. Start date: Jun 2007 to not statedv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the trial is to evaluate the effect upon immune system of two regimens of preventive HIV vaccination in healthy adult volunteers. Volunteers will be vaccinated by DNA-C and NYVAC-C vaccines, and the immune changes will be assessed, as well as safety of the vaccines. Volunteers will be followed during 72 weeks.
Trial Details
NCT Number NCT00490074
Lead Sponsor ANRS, Emerging Infectious Diseases
Collaborators: EuroVacc Foundation
Conditions HIV Infections
Enrollment 147 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov